col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Elsevier: Life Sciences
  original article Date Title Authors   All Authors
1 [GO] 2021―May―18 Soluble P-selectin as a potential diagnostic and prognostic biomarker for COVID-19 disease: A case-control study Emre Karsli, Ramazan Sabirli, Emel Altintas, Omer Canacik, Gizem Tukenmez Sabirli, Buse Kaymaz, et al. (+2)
2 [GO] 2021―May―12 Various theranostics and immunization strategies based on nanotechnology against Covid-19 pandemic: An interdisciplinary view Sujan Chatterjee, Snehasis Mishra, Kaustav Dutta Chowdhury, Chandan Kumar Ghosh, Krishna Das Saha
3 [GO] 2021―May―10 Beclin-1, an autophagy-related protein, is associated with the disease severity of COVID-19 Hamza Malik Okuyan, Serdar Dogan, Tayibe Bal, Mehmet Çabalak
4 [GO] 2021―Apr―16 Therapeutic potential of mesenchymal stem cells in multiple organs affected by COVID-19 Gustavo C. Paris, Aline de A. Azevedo, Adriana L. Ferreira, Yanca M. de A. Azevedo, Mateus A. Rainho, Genilza P. de Oliveira, et al. (+6)
5 [GO] 2021―Apr―16 Risk factors for adverse outcomes of COVID-19 patients: Possible basis for diverse responses to the novel coronavirus SARS-CoV-2 Mahnaz Ghaebi, Safa Tahmasebi, Maryam Jozghorbani, Alireza Sadeghi, Lakshmi Thangavelu, Angelina Olegovna Zekiy, Abdolreza Esmaeilzadeh
6 [GO] 2021―Mar―28 Nanocurcumin improves Treg cell responses in patients with mild and severe SARS-CoV2 Safa Tahmasebi, Balsam Qubais Saeed, Elmira Temirgalieva, Alexei Valerievich Yumashev, Mohamed A. El-Esawi, Jamshid Gholizadeh Navashenaq, et al. (+8)
7 [GO] 2021―Mar―27 Heparin prevents in vitro glycocalyx shedding induced by plasma from COVID-19 patients Simone R. Potje, Tiago J. Costa, Thais F.C. Fraga-Silva, Ronaldo B. Martins, Maira N. Benatti, Carlos E.L. Almado, et al. (+9)
8 [GO] 2021―Mar―24 Dipeptidylpeptidase-4 levels and DPP4 gene polymorphisms in patients with COVID-19. Association with disease and with severity Rosalinda Posadas-Sánchez, Fausto Sánchez-Muñoz, Carlos Alfonso Guzmán Martin, Adrian Hernández-Díaz Couder, Gustavo Rojas-Velasco, José Manuel Fragoso, Gilberto Vargas-Alarcón
9 [GO] 2021―Mar―19 Effects of metformin, insulin on COVID-19 patients with pre-existed type 2 diabetes: A multicentral retrospective study Xueqi Cheng, Siyi Xin, Yaqi Chen, Leyu Li, Wanjun Chen, Wenjia Li, et al. (+6)
10 [GO] 2021―Mar―12 Implications of microscale lung damage for COVID-19 pulmonary ventilation dynamics: A narrative review Elizabeth Dimbath, Veeranna Maddipati, Jennifer Stahl, Kerry Sewell, Zachary Domire, Stephanie George, Ali Vahdati
11 [GO] 2021―Mar―05 The significance of bioengineered nanoplatforms against SARS-CoV-2: From detection to genome editing Parichehr Hassanzadeh
12 [GO] 2021―Feb―23 Targeting RAGE to prevent SARS-CoV-2-mediated multiple organ failure: Hypotheses and perspectives Sara Chiappalupi, Laura Salvadori, Aleksandra Vukasinovic, Rosario Donato, Guglielmo Sorci, Francesca Riuzzi
13 [GO] 2021―Feb―17 COVID-19, cytokines, inflammation, and spices: How are they related? Ajaikumar B. Kunnumakkara, Varsha Rana, Dey Parama, Kishore Banik, Sosmitha Girisa, Henamayee Sahu, et al. (+5)
14 [GO] 2021―Feb―17 A double edged-sword - The Complement System during SARS-CoV-2 infection Lazara Elena Santiesteban-Lores, Thais Akemi Amamura, Tiago Francisco da Silva, Leonardo Moura Midon, Milena Carvalho Carneiro, Lourdes Isaac, Lorena Bavia
15 [GO] 2021―Feb―09 Screening of severe acute respiratory syndrome coronavirus-2 infection during labor and delivery using polymerase chain reaction and immunoglobulin testing Ricardo Savirón-Cornudella, Ana Villalba, Luis M. Esteban, Mauricio Tajada, Belén Rodríguez-Solanilla, Mercedes Andeyro-Garcia, et al. (+4)
16 [GO] 2021―Jan―27 SARS-CoV-2 infection: The role of PD-1/PD-L1 and CTLA-4 axis Parisa Shiri Aghbash, Narges Eslami, Ali Shamekh, Taher Entezari-Maleki, Hossein Bannazadeh Baghi
17 [GO] 2021―Jan―26 Biosensors as a future diagnostic approach for COVID-19 Suhad Abbas Abid, Ahmed Suhail, Israa M.S. Al-Kadmy, Anas A. Sattar, Amany Magdy Beshbishy, Gaber El-Saber Batiha, Helal F. Hetta
18 [GO] 2021―Jan―26 Cardiovascular protective properties of oxytocin against COVID-19 Stephani C. Wang, Yu-Feng Wang
19 [GO] 2021―Jan―19 Statistical analysis of COVID-19 infection caused by environmental factors: Evidence from Pakistan Muhammad Fawad, Sumaira Mubarik, Saima Shakil Malik, Jingli Ren
20 [GO] 2021―Jan―15 Monocytes and macrophages in COVID-19: Friends and foes Sepideh Meidaninikjeh, Nasim Sabouni, Hadi Zare Marzouni, Sajad Bengar, Ahmad Khalili, Reza Jafari
21 [GO] 2021―Jan―14 The proteomic characteristics of airway mucus from critical ill COVID-19 patients Zili Zhang, Tao Wang, Fei Liu, Airu Zhu, Guoping Gu, Jieping Luo, et al. (+7)
22 [GO] 2021―Jan―14 Interferon-γ-induced protein 10 (IP-10) and serum amyloid A (SAA) are excellent biomarkers for the prediction of COVID-19 progression and severity Riham Abdel-Hamid Haroun, Waleed H. Osman, Asmaa M. Eessa
23 [GO] 2020―Dec―23 Targeting inflammatory cytokine storm to fight against COVID-19 associated severe complications Rishabh Hirawat, Mohd Aslam Saifi, Chandraiah Godugu
24 [GO] 2020―Dec―19 DNA vaccines against COVID-19: Perspectives and challenges Marcelle Moura Silveira, Gustavo Marçal Schmidt Garcia Moreira, Marcelo Mendonça
25 [GO] 2020―Dec―11 Repurposing of histone deacetylase inhibitors: A promising strategy to combat pulmonary fibrosis promoted by TGF-β signalling in COVID-19 survivors P. Krishna Murthy, Karthikeyan Sivashanmugam, Mahesh Kandasamy, Rajasekaran Subbiah, Vilwanathan Ravikumar
26 [GO] 2020―Dec―10 Screened antipsychotic drugs inhibit SARS-CoV-2 binding with ACE2 in vitro Jiayu Lu, Yajing Hou, Shuai Ge, Xiangjun Wang, Jue Wang, Tian Hu, et al. (+3)
27 [GO] 2020―Nov―19 High GRP78 levels in Covid-19 infection: A case-control study Ramazan Sabirli, Aylin Koseler, Tarik Goren, Ibrahim Turkcuer, Ozgur Kurt
28 [GO] 2020―Oct―28 Is highly expressed ACE 2 in pregnant women “a curse” in times of COVID-19 pandemic? Ankit Dhaundiyal, Puja Kumari, Snehal Sainath Jawalekar, Gaurav Chauhan, Sourav Kalra, Umashanker Navik
29 [GO] 2020―Oct―26 The impact of oxidative stress damage induced by the environmental stressors on COVID-19 Bianza Moise Bakadia, Biaou Oscar Ode Boni, Abeer Ahmed Qaed Ahmed, Guang Yang
30 [GO] 2020―Oct―10 Mesenchymal stem cell immunomodulation and regeneration therapeutics as an ameliorative approach for COVID-19 pandemics Pooja Yadav, Ravina Vats, Afsareen Bano, Rashmi Bhardwaj
31 [GO] 2020―Oct―06 Involvement of the nervous system in COVID-19: The bell should toll in the brain Sairaj Satarker, Madhavan Nampoothiri
32 [GO] 2020―Oct―06 Can endolysosomal deacidification and inhibition of autophagy prevent severe COVID-19? Gerwyn Morris, Eugene Athan, Ken Walder, Chiara C. Bortolasci, Adrienne O'Neil, Wolf Marx, et al. (+4)
33 [GO] 2020―Sep―28 Pharmacological agents to therapeutic treatment of cardiac injury caused by Covid-19 A. Vitiello, F. Ferrara
34 [GO] 2020―Sep―23 Mesenchymal stem cell therapies for COVID-19: Current status and mechanism of action Somaye Sadeghi, Sara Soudi, Abbas Shafiee, Seyed Mahmoud Hashemi
35 [GO] 2020―Sep―21 Cardiac inflammation in COVID-19: Lessons from heart failure Sathya D. Unudurthi, Priya Luthra, Rajendran J.C. Bose, Jason McCarthy, Maria Irene Kontaridis
36 [GO] 2020―Sep―18 Assessment of effective imidazole derivatives against SARS-CoV-2 main protease through computational approach Assia Belhassan, Fatima En-nahli, Hanane Zaki, Tahar Lakhlifi, Mohammed Bouachrine
37 [GO] 2020―Sep―15 SARS-CoV-2 and coagulation disorders in different organs Sathishkumar Vinayagam, Kamaraj Sattu
38 [GO] 2020―Sep―11 New insight on possible vaccine development against SARS-CoV-2 Sundas Nasir Chaudhry, Abu Hazafa, Muhummad Mumtaz, Ume Kalsoom, Saima Abbas, Amna Kainaat, et al. (+4)
39 [GO] 2020―Sep―09 Parameters predicting COVID-19-induced myocardial injury and mortality G.D. Duerr, A. Heine, M. Hamiko, S. Zimmer, J.A. Luetkens, J. Nattermann, et al. (+13)
40 [GO] 2020―Aug―23 Correlation of D-xylose with severity and morbidity-related factors of COVID-19 and possible therapeutic use of D-xylose and antibiotics for COVID-19 Antony Cheudjeu
41 [GO] 2020―Aug―23 Attaching clinical significance to COVID-19-associated diarrhea Fantao Wang, Shiliang Zheng, Chengbin Zheng, Xiaodong Sun
42 [GO] 2020―Aug―23 COVID-19: Pathophysiology, treatment options, nanotechnology approaches, and research agenda to combating the SARS-CoV2 pandemic Valamla Bhavana, Pradip Thakor, Shashi Bala Singh, Neelesh Kumar Mehra
43 [GO] 2020―Aug―21 Variability in genes related to SARS-CoV-2 entry into host cells (ACE2, TMPRSS2, TMPRSS11A, ELANE, and CTSL) and its potential use in association studies Gilberto Vargas-Alarcón, Rosalinda Posadas-Sánchez, Julian Ramírez-Bello
44 [GO] 2020―Aug―17 Utilizing drug repurposing against COVID-19 - Efficacy, limitations, and challenges Vineela Parvathaneni, Vivek Gupta
45 [GO] 2020―Aug―08 Anti-HCV and anti-malaria agent, potential candidates to repurpose for coronavirus infection: Virtual screening, molecular docking, and molecular dynamics simulation study Faezeh Sadat Hosseini, Massoud Amanlou
46 [GO] 2020―Aug―07 Molecular diagnosis of COVID-19 in different biologic matrix, their diagnostic validity and clinical relevance: A systematic review Saniya Mahendiratta, Gitika Batra, Phulen Sarma, Harish Kumar, Seema Bansal, Subodh Kumar, et al. (+3)
47 [GO] 2020―Aug―03 Role of comorbidities like diabetes on severe acute respiratory syndrome coronavirus-2: A review Subham Das, K.R. Anu, Sumit Raosaheb Birangal, Ajinkya Nitin Nikam, Abhijeet Pandey, Srinivas Mutalik, Alex Joseph
48 [GO] 2020―Aug―01 The immune system as a target for therapy of SARS-CoV-2: A systematic review of the current immunotherapies for COVID-19 Amir Hossein Mansourabadi, Mona Sadeghalvad, Hamid-Reza Mohammadi-Motlagh, Nima Rezaei
49 [GO] 2020―Jul―31 The pathophysiology of SARS-CoV-2: A suggested model and therapeutic approach Gerwyn Morris, Chiara C. Bortolasci, Basant K. Puri, Lisa Olive, Wolfgang Marx, Adrienne O'Neil, et al. (+5)
50 [GO] 2020―Jul―29 The role of cytokine profile and lymphocyte subsets in the severity of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis Hamed Akbari, Reza Tabrizi, Kamran B. Lankarani, Hamid Aria, Sina Vakili, Fatemeh Asadian, et al. (+3)
51 [GO] 2020―Jul―29 Molecular profiling of immune cell-enriched Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) interacting protein USP13 Burcu Biterge Süt
52 [GO] 2020―Jul―29 Computational guided drug repurposing for targeting 2′-O-ribose methyltransferase of SARS-CoV-2 Kedar Sharma, Sudhir Morla, Arun Goyal, Sachin Kumar
53 [GO] 2020―Jul―24 The interaction of RAAS inhibitors with COVID-19: Current progress, perspective and future Jishou Zhang, Menglong Wang, Wen Ding, Jun Wan
54 [GO] 2020―Jul―18 Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions Abdollah Jafarzadeh, Prashant Chauhan, Bhaskar Saha, Sara Jafarzadeh, Maryam Nemati
55 [GO] 2020―Jul―18 Emerging role of IL-6 and NLRP3 inflammasome as potential therapeutic targets to combat COVID-19: Role of lncRNAs in cytokine storm modulation Alireza Paniri, Haleh Akhavan-Niaki
56 [GO] 2020―Jul―17 An updated insight into the molecular pathogenesis, secondary complications and potential therapeutics of COVID-19 pandemic Sumit Jamwal, Akash Gautam, John Elsworth, Mandeep Kumar, Rakesh Chawla, Puneet Kumar
57 [GO] 2020―Jul―15 The bio-mission of interleukin-6 in the pathogenesis of COVID-19: A brief look at potential therapeutic tactics Mitra Abbasifard, Hossein Khorramdelazad
58 [GO] 2020―Jul―15 Matrix metallopeptidase 9 as a host protein target of chloroquine and melatonin for immunoregulation in COVID-19: A network-based meta-analysis Suvojit Hazra, Alok Ghosh Chaudhuri, Basant K. Tiwary, Nilkanta Chakrabarti
59 [GO] 2020―Jul―12 Tackling the cytokine storm in COVID-19, challenges, and hopes Shifaa M. Abdin, Sara M. Elgendy, Shatha K. Alyammahi, Dima W. Alhamad, Hany A. Omar
60 [GO] 2020―Jul―10 The dual impact of ACE2 in COVID-19 and ironical actions in geriatrics and pediatrics with possible therapeutic solutions Tapan Behl, Ishnoor Kaur, Simona Bungau, Arun Kumar, Md Sahab Uddin, Chanchal Kumar, et al. (+4)
61 [GO] 2020―Jul―09 Update on neurological manifestations of COVID-19 Hanie Yavarpour-Bali, Maryam Ghasemi-Kasman
62 [GO] 2020―Jul―09 Gaining insights on immune responses to the novel coronavirus, COVID-19 and therapeutic challenges Mahsa Hajivalili, Maryam Hosseini, Mostafa Haji-Fatahaliha
63 [GO] 2020―Jul―09 Computational insights into tetracyclines as inhibitors against SARS-CoV-2 Mpro via combinatorial molecular simulation calculations Shiv Bharadwaj, Kyung Eun Lee, Vivek Dhar Dwivedi, Sang Gu Kang
64 [GO] 2020―Jul―06 Structural features of coronavirus SARS-CoV-2 spike protein: Targets for vaccination Ariane Sternberg, Cord Naujokat
65 [GO] 2020―Jun―15 Potential inhibitors of the interaction between ACE2 and SARS-CoV-2 (RBD), to develop a drug Claudia Guadalupe Benítez-Cardoza, José Luis Vique-Sánchez
66 [GO] 2020―Jun―12 Vaccination strategies to combat novel corona virus SARS-CoV-2 Satish Chandra Pandey, Veni Pande, Diksha Sati, Shobha Upreti, Mukesh Samant
67 [GO] 2020―Jun―11 Virtual screening, ADME/Tox predictions and the drug repurposing concept for future use of old drugs against the COVID-19 Lorane Izabel da Silva Hage-Melim, Leonardo Bruno Federico, Nayana Keyla Seabra de Oliveira, Viviane Cristina Cardoso Francisco, Lenir Cabral Correa, Henrique Barros de Lima, et al. (+4)
68 [GO] 2020―Jun―03 Is melatonin deficiency a unifying pathomechanism of high risk patients with COVID-19? Fedor Simko, Russel J. Reiter
69 [GO] 2020―Jun―03 Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to Macrophage Activation Syndrome: Therapeutic implications Nehla Banu, Sandeep Surendra Panikar, Lizbeth Riera Leal, Annie Riera Leal
70 [GO] 2020―Jun―02 The immune system and COVID-19: Friend or foe? Fereshteh Yazdanpanah, Michael R. Hamblin, Nima Rezaei
71 [GO] 2020―Jun―01 Potential therapeutic targets for combating SARS-CoV-2: Drug repurposing, clinical trials and recent advancements Abhjieet Pandey, Ajinkya Nitin Nikam, Ajjappla Basavraj Shreya, Sadhana P. Mutalik, Divya Gopalan, Sanjay Kulkarni, et al. (+4)
72 [GO] 2020―May―23 Crosstalk between endoplasmic reticulum stress and anti-viral activities: A novel therapeutic target for COVID-19 Aditi Banerjee, Steven J. Czinn, Russel J. Reiter, Thomas G. Blanchard
73 [GO] 2020―May―22 Coronaviruses pandemics: Can neutralizing antibodies help? Phuoc-Bao-Viet Tong, Li-Yun Lin, Tuan Hiep tran
74 [GO] 2020―May―22 Coronaviruses pathogenesis, comorbidities and multi-organ damage - A review Pureti Lakshmi Prasanna, V.G. Abilash
75 [GO] 2020―May―22 Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 Mpro enzyme through in silico approach Arun Bahadur Gurung, Mohammad Ajmal Ali, Joongku Lee, Mohammad Abul Farah, Khalid Mashay Al-Anazi
76 [GO] 2020―May―15 Lungs as target of COVID-19 infection: Protective common molecular mechanisms of vitamin D and melatonin as a new potential synergistic treatment Virna Margarita Martín Giménez, Felipe Inserra, Carlos D. Tajer, Javier Mariani, León Ferder, Russel J. Reiter, Walter Manucha
77 [GO] 2020―May―13 The role of biomarkers in diagnosis of COVID-19 - A systematic review Muhammed Kermali, Raveena Kaur Khalsa, Kiran Pillai, Zahra Ismail, Amer Harky
78 [GO] 2020―May―11 A systematic review on use of aminoquinolines for the therapeutic management of COVID-19: Efficacy, safety and clinical trials Vaishali M. Patil, Shipra Singhal, Neeraj Masand
79 [GO] 2020―May―08 The current understanding and potential therapeutic options to combat COVID-19 Venkatesh Pooladanda, Sowjanya Thatikonda, Chandraiah Godugu
80 [GO] 2020―Apr―30 Comment on Melatonin as a potential adjuvant treatment for COVID-19 Emilio A. Herrera, Alejandro Gonzalez-Candia
81 [GO] 2020―Apr―29 Myocardial injury and COVID-19: Possible mechanisms Savalan Babapoor-Farrokhran, Deanna Gill, Jackson Walker, Roozbeh Tarighati Rasekhi, Behnam Bozorgnia, Aman Amanullah
82 [GO] 2020―Apr―23 Correspondence COVID-19: Melatonin as a potential adjuvant treatment Cristina Salles
83 [GO] 2020―Apr―10 In silico studies on therapeutic agents for COVID-19: Drug repurposing approach Bhumi Shah, Palmi Modi, Sneha R. Sagar
84 [GO] 2020―Apr―04 Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease Mahmoud Kandeel, Mohammed Al-Nazawi
85 [GO] 2020―Mar―25 Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study Abdo A. Elfiky
86 [GO] 2020―Mar―23 COVID-19: Melatonin as a potential adjuvant treatment Rui Zhang, Xuebin Wang, Leng Ni, Xiao Di, Baitao Ma, Shuai Niu, et al. (+2)
87 [GO] 2020―Feb―28 Anti-HCV, nucleotide inhibitors, repurposing against COVID-19 Abdo A. Elfiky


[de][en]

Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.005 sec